AstraZeneca PLC Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | AstraZeneca PLC

AstraZeneca PLC

AstraZeneca PLC ADR
Stock Exchange	New York Stock Exchange
EPS	$0.95
Market Cap	$107.41 B
Shares Outstanding	2.62 B
Public Float	2.53 B

AstraZeneca PLC
Stock Exchange	Other OTC
EPS	$1.9
Market Cap	$108.69 B
Shares Outstanding	1.27 B
Public Float	-

AstraZeneca PLC
Stock Exchange	London Stock Exchange
EPS	GBP1.46
Market Cap	GBP85.62 B
Shares Outstanding	1.27 B
Public Float	1.2 B

AstraZeneca PLC ADR
Stock Exchange	Frankfurt Stock Exchange
EPS	EUR0.83
Market Cap	EUR96.55 B
Shares Outstanding	2.53 B
Public Float	-

AstraZeneca PLC
Stock Exchange	OTC Publication Venue
EPS	SEK17.11
Market Cap	SEK1.02 T
Shares Outstanding	1.27 B
Public Float	-

AstraZeneca PLC
Stock Exchange	Xetra Stock Exchange
EPS	EUR1.65
Market Cap	EUR101.01 B
Shares Outstanding	1.27 B
Public Float	-

AstraZeneca PLC ADR
Stock Exchange	Mexican Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	2.53 B
Public Float	-

Profile

Address	Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AA United Kingdom
Employees	-
Website	http://astrazeneca.com
Updated	07/08/2019
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 0382, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta.

Financials

Pascal Soriot

Chief Executive Officer & Executive Director

Marc Dunoyer

Chief Financial Officer & Executive Director